Prague Med. Rep. 2021, 122, 300-307

https://doi.org/10.14712/23362936.2021.28

Spontaneous Multiple Haematomas in a Patient with Severe COVID-19 Fully Recovered with a Conservative Approach

Roya Alavi-Naini1, Farzaneh Gorgani1, Zohre Rahmati1, Saemeh Pourdehghan1, Maryam Keikha2, Zahra Farzad3

1Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran
2Department of Radiology, Children and Adolescents Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3Medical Doctor, International Medical Graduate, Representative of the International Clinical Research Academy, Toronto, Canada

Received June 11, 2021
Accepted October 20, 2021

References

1. Al-Samkari, H., Karp Leaf, R. S., Dzik, W. H., Carlson, J. C. T., Fogerty, A. E., Waheed, A., Goodarzi, K., Bendapudi, P. K., Bornikova, L., Gupta, S., Leaf, D. E., Kuter, D. J., Rosovsky, R. P. (2020) COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136(4), 489–500. <https://doi.org/10.1182/blood.2020006520>
2. Lutz, J., Menke, J., Sollinger, D., Schinzel, H., Thurmel, K. (2014) Haemostasis in chronic kidney disease. Nephrol. Dial. Transplant. 29(1), 29–40. <https://doi.org/10.1093/ndt/gft209>
3. Mattioli, M., Benfaremo, D., Fustini, E., Gennarini, S. (2020) Atypical spontaneous hematomas in a patient with severe coronavirus disease 2019 (COVID-19). Semin. Thromb. Hemost. 46(7), 856–858.
4. Miesbach, W., Makris, M. (2020) COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin. Appl. Thromb. Hemost. 26, 1076029620938149. <https://doi.org/10.1177/1076029620938149>
5. Moreno, G., Carbonell, R., Bodi, M., Rodriguez, A. (2021) Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients. Med. Intensiva (Engl. Ed.) 45(1), 42–55. (in English, Spanish) <https://doi.org/10.1016/j.medin.2020.06.006>
6. Nakamura, H., Ouchi, G., Miyagi, K., Higure, Y., Otsuki, M., Nishiyama, N., Kinjo, T., Nakamatsu, M., Tateyama, M., Kukita, I., Fujita, J. (2021) Case report: Iliopsoas hematoma during the clinical course of severe COVID-19 in two male patients. Am. J. Trop. Med. Hyg. 104(3), 1018–1021. <https://doi.org/10.4269/ajtmh.20-1507>
7. Pavord, S., Myers, B. (2011) Bleeding and thrombotic complications of kidney disease. Blood Rev. 25(6), 271–278. <https://doi.org/10.1016/j.blre.2011.07.001>
8. Shah, A., Donovan, K., McHugh, A., Pandey, M., Aaron, L., Bradbury, C. A., Stanworth, S. J., Alikhan, R., Von Kier, S., Maher, K., Curry, N., Shapiro, S., Rowland, M. J., Thomas, M., Mason, R., Holland, M., Holmes, T., Ware, M., Gurney, S., McKechnie, S. R. (2020) Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: A multicentre observational study. Crit. Care 24(1), 561. <https://doi.org/10.1186/s13054-020-03260-3>
9. Tang, N., Li, D., Wang, X., Sun, Z. (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18(4), 844–847. <https://doi.org/10.1111/jth.14768>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive